MagnePath is a digital health company, with foundations in medical device/software, developing a software platform & tissue mapping applications as the next generation of quantitative magnetic resonance imaging (qMRI) technology. Our applications address unmet medical needs and target several of the most important chronic diseases. LiverMap, is positioned as a "Virtual Liver Biopsy" to displace the expensive, invasive, and lengthy Needle Biopsy.

MagnePath Corporation
Developing Imaging Biomarkers as Phenotypic Endpoints for Body Analytics, in order to replace invasive diagnostic procedures. Virtual Liver Biopsy by LiverMap.
About MagnePath Corporation
You need to register as an accredited investor before we can show you the details of any investment opportunities.
VentureHealth is currently invite only.
Request An Invite!Startup's Info
Location:
New York
Markets:
Medical Devices, Diagnostics, Other
Therapeutic Areas:
Hepatology, Other